Plurify
- Biotech or pharma, therapeutic R&D
- CMO, CRO
Plurify, based in Cambridge, UK, have engineered stable cell lines from RNA, with their breakthrough long-lasting RNA platform for fully controllable gene delivery in-vitro for over 100 days - delivering up to 10KB of genetic cargo in a single RNA.
This agile, cost-effective, and flexible system empowers drug discovery workflows (cell engineering with transcription factors, receptor expression, assay development) and large-scale biomanufacturing applications such as stem cell therapy engineering and scalable cell purification, or AAV production. Our disruptive RNA approach streamlines process development, enhances product consistency, and reduces timelines and costs.
We are actively seeking pilot collaborations with leading pharma and biotech therapy developers to solve their challenges.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}